An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)
Clinical trial NCT00242736 · COMPLETED
Trial details
- NCT number
- NCT00242736
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.